CRKL expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.52851081686367E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.33149999973037E-07 |
Normal-vs-Stage2 |
8.38749999454436E-08 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.758100E-03 |
Stage1-vs-Stage2 |
9.984400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.977400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.492400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.20540261000701E-11 |
Normal-vs-AfricanAmerican |
2.592600E-01 |
Normal-vs-Asian |
2.4524999999942E-05 |
Caucasian-vs-AfricanAmerican |
1.784200E-01 |
Caucasian-vs-Asian |
8.820800E-01 |
AfricanAmerican-vs-Asian |
3.440000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.97050000053601E-07 |
Normal-vs-Female |
3.33940000096788E-08 |
Male-vs-Female |
9.018000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.025300E-04 |
Normal-vs-Extreme_Weight |
5.37849999981965E-07 |
Normal-vs-Obese |
7.59310000000291E-05 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.249000E-01 |
Normal_Weight-vs-Obese |
1.326120E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.877640E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.996400E-01 |
Normal-vs-Age(41-60Yrs) |
1.993000E-04 |
Normal-vs-Age(61-80Yrs) |
1.28889999784221E-08 |
Normal-vs-Age(81-100Yrs) |
1.511570E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.222200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.270000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.857400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.124400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.289000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.326800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.043400E-01 |
Normal-vs-Grade 3 |
6.458800E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.904200E-01 |
Grade 2-vs-Grade 4 |
4.043400E-01 |
Grade 3-vs-Grade 4 |
6.458800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.75359998428371E-10 |
Normal-vs-N1 |
2.784600E-03 |
N0-vs-N1 |
4.437200E-01 |
|
|